Saudi Al Hobail Medical Seeks Indian Pharma Partners for Market Expansion

A significant business opportunity has emerged for Indian pharmaceutical exporters looking to strengthen their footprint in the Middle East. Riyadh-based Al Hobail Medical Company is actively seeking Indian manufacturing partners to facilitate the registration and commercialization of a specific portfolio of pharmaceutical products within Saudi Arabia. This initiative, communicated through the Pharmaceuticals Export Promotion Council of India (Pharmexcil), aims to bridge the gap between Indian manufacturing capabilities and the growing Saudi Arabian healthcare sector.

Expanding into Saudi Arabia

Indian pharmaceutical companies have been invited to explore this collaboration, which offers a strategic pathway into the Kingdom's institutional procurement systems and private distribution networks. As the industry looks toward Saudi Arabia, firms must ensure their product portfolios align with the specific requirements outlined by the Saudi partner. Under the proposed arrangement, Al Hobail Medical Company will serve as the Marketing Authorisation Holder (MAH), managing the regulatory registration process for selected products. Once registered, these pharmaceuticals will be distributed through key channels, including the National Unified Procurement Company (NUPCO), the Saudi Ministry of Health (MOH), and private healthcare institutions.

To participate, manufacturers must demonstrate that they meet rigorous regulatory and documentation standards. This includes the possession of valid Good Manufacturing Practice (GMP) certificates, Certificates of Pharmaceutical Product (COPP), and active manufacturing licences. Furthermore, companies are expected to provide submission-ready Common Technical Document (CTD) or electronic Common Technical Document (eCTD) dossiers. Given the specific climatic conditions of the region, manufacturers must also supply Zone IVb stability data. Where applicable, bioequivalence (BE) study reports will be mandatory for product approval.

Indian manufacturers are invited to partner with Al Hobail Medical to register and sell drugs in Saudi Arabia.

Pharmexcil Director General K Raja Bhanu has encouraged eligible members to review the product requirement list and engage directly with the Saudi firm. Interested parties are required to submit detailed corporate profiles, facility information, and documentation status to Mohammed Sadiq Ahmed, the tender manager at Al Hobail Medical Company. By aligning with a local partner, Indian exporters can effectively navigate the regulatory landscape and gain access to both government and private healthcare procurement in the region.

Why it matters

This partnership provides a structured framework for Indian pharmaceutical companies to diversify their export markets and establish a sustainable commercial presence in Saudi Arabia. By leveraging local expertise for regulatory compliance, Indian manufacturers can scale their operations and gain direct access to major public health procurement channels in the Kingdom.